LivaNova PLC (LIVN) Position Boosted by Paradice Investment Management LLC
Paradice Investment Management LLC boosted its position in shares of LivaNova PLC (NASDAQ:LIVN) by 36.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,321 shares of the company’s stock after buying an additional 20,100 shares during the period. Paradice Investment Management LLC owned about 0.15% of LivaNova PLC worth $4,610,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in LIVN. Meadow Creek Investment Management LLC raised its stake in LivaNova PLC by 11.4% in the first quarter. Meadow Creek Investment Management LLC now owns 2,464 shares of the company’s stock worth $121,000 after buying an additional 252 shares in the last quarter. Icon Advisers Inc. Co. bought a new position in shares of LivaNova PLC during the first quarter worth approximately $333,000. Swiss National Bank increased its position in shares of LivaNova PLC by 1.8% in the first quarter. Swiss National Bank now owns 72,719 shares of the company’s stock worth $3,564,000 after buying an additional 1,300 shares during the last quarter. Comerica Bank increased its position in shares of LivaNova PLC by 3.8% in the first quarter. Comerica Bank now owns 31,907 shares of the company’s stock worth $1,672,000 after buying an additional 1,182 shares during the last quarter. Finally, Cambiar Investors LLC increased its position in shares of LivaNova PLC by 16.9% in the first quarter. Cambiar Investors LLC now owns 7,841 shares of the company’s stock worth $384,000 after buying an additional 1,136 shares during the last quarter. Institutional investors and hedge funds own 82.36% of the company’s stock.
LivaNova PLC (NASDAQ LIVN) opened at 61.49 on Tuesday. LivaNova PLC has a 12 month low of $40.83 and a 12 month high of $64.95. The company’s 50-day moving average is $61.60 and its 200-day moving average is $56.05. The stock has a market capitalization of $3.00 billion, a P/E ratio of 109.80 and a beta of 0.62.
LivaNova PLC (NASDAQ:LIVN) last issued its earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The company had revenue of $321.40 million for the quarter, compared to analyst estimates of $315.75 million. The firm’s revenue was up .1% compared to the same quarter last year. Equities analysts anticipate that LivaNova PLC will post $3.22 earnings per share for the current year.
A number of research analysts recently commented on the stock. Berenberg Bank reaffirmed a “buy” rating and set a $70.00 price objective on shares of LivaNova PLC in a research report on Friday, August 11th. BidaskClub downgraded shares of LivaNova PLC from a “buy” rating to a “hold” rating in a research report on Tuesday, August 1st. WBB Securities downgraded shares of LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective on the stock. in a research report on Tuesday, August 15th. Finally, Needham & Company LLC assumed coverage on shares of LivaNova PLC in a research report on Wednesday, August 23rd. They set a “hold” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. LivaNova PLC has an average rating of “Hold” and an average target price of $58.00.
In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $60.76, for a total transaction of $60,760.00. Following the transaction, the director now directly owns 58,296 shares of the company’s stock, valued at $3,542,064.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have sold 3,000 shares of company stock worth $183,110 over the last ninety days. 0.28% of the stock is owned by insiders.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Stock Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related stocks with our FREE daily email newsletter.